26 Nov 21 | 16:00
Thyrocare Technologies Ltd
Exchange Received Time
Exchange Disseminated Time
Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 |
The Board of Directors of the Company in their meeting held on 6 October 2021 have, inter alia, taken the following decisions: (a) Appointment of Dr. Dhaval Rajesh Shah as additional Director (b) Appointment of Ernst & Young as Internal Auditors of the Company for the year 2021-22 (c) Issue and allotment of 28,913 equity shares to the eligible employees under ESOP Scheme.
Copyright@ 2015. All Rights Reserved.
27 Nov 21|14:38 (IST)